Australia markets closed

Fisher & Paykel Healthcare Corporation Limited (FPH.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
25.22-0.23 (-0.90%)
At close: 04:10PM AEST
Currency in AUD

Valuation measures4

Market cap (intra-day) 14.57B
Enterprise value 14.80B
Trailing P/E 61.49
Forward P/E 47.17
PEG ratio (5-yr expected) 4.47
Price/sales (ttm)9.41
Price/book (mrq)9.17
Enterprise value/revenue 8.66
Enterprise value/EBITDA 31.40

Trading information

Stock price history

Beta (5Y monthly) 0.41
52-week change 3-1.18%
S&P500 52-week change 322.36%
52-week high 326.08
52-week low 318.58
50-day moving average 323.42
200-day moving average 321.73

Share statistics

Avg vol (3-month) 3297.57k
Avg vol (10-day) 3360.22k
Shares outstanding 5582.17M
Implied shares outstanding 6592.29M
Float 8579.86M
% held by insiders 19.41%
% held by institutions 137.81%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.33
Forward annual dividend yield 41.32%
Trailing annual dividend rate 30.41
Trailing annual dividend yield 31.61%
5-year average dividend yield 41.36
Payout ratio 479.61%
Dividend date 3N/A
Ex-dividend date 405 Dec 2023
Last split factor 25:1
Last split date 327 Sept 2004

Financial highlights

Currency in NZD.

Fiscal year

Fiscal year ends 31 Mar 2023
Most-recent quarter (mrq)30 Sept 2023

Profitability

Profit margin 15.45%
Operating margin (ttm)18.99%

Management effectiveness

Return on assets (ttm)9.98%
Return on equity (ttm)16.20%

Income statement

Revenue (ttm)1.69B
Revenue per share (ttm)2.92
Quarterly revenue growth (yoy)16.40%
Gross profit (ttm)N/A
EBITDA 438.4M
Net income avi to common (ttm)261.7M
Diluted EPS (ttm)0.41
Quarterly earnings growth (yoy)11.90%

Balance sheet

Total cash (mrq)70.5M
Total cash per share (mrq)0.12
Total debt (mrq)323.4M
Total debt/equity (mrq)18.46%
Current ratio (mrq)2.54
Book value per share (mrq)3.01

Cash flow statement

Operating cash flow (ttm)392.8M
Levered free cash flow (ttm)-87.96M